# FDA 483 - Airgas USA LLC - February 18, 2022

Source: https://www.keypedia.com/records/483/airgas-usa-llc/05edabe0-37e0-4b15-8ba5-a194b4d4942c

> FDA 483 for Airgas USA LLC on February 18, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Airgas USA LLC
- Inspection Date: 2022-02-18
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Airgas USA LLC in South Salt Lake, UT, identified significant deficiencies in the control and security of drug product labels for medical gases. The firm failed to ensure adequate physical separation of labels during production and allowed unauthorized personnel unrestricted access to labeling materials. These conditions indicate a lack of proper controls, increasing the risk of label mix-ups and cross-contamination.

## Related Documents

- [483 - 2019-10-25](https://www.keypedia.com/records/483/airgas-usa-llc/5344a1f1-8d4f-4dc7-8f98-1ca71f068edc)
- [483 - 2024-12-16](https://www.keypedia.com/records/483/airgas-usa-llc/38c9899a-eaec-4645-aef2-11b5b1028ff4)

## Related Officers

- [Matthew R. Clabeaux](https://www.keypedia.com/people/matthew-r-clabeaux/9acc9b47-4063-4582-ac9a-983a07079495)

Company: https://www.keypedia.com/companies/airgas-usa-llc/3182ac01-b267-4631-b3a9-6feb4b61b90c

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face